Press Release

Oncotarget Participation at SSP 2025 Annual Meeting


FOR IMMEDIATE RELEASE
2025-05-05

Oncotarget will be represented by Impact Journals as an exhibitor at the Society for Scholarly Publishing (SSP) 47th Annual Meeting, taking place from May 28–30, 2025, in Baltimore, Maryland.


BUFFALO, NY - May 5, 2025 –
Oncotarget, published by Impact Journals, is proud to announce its presence as an exhibitor at the 47th Annual Meeting of the Society for Scholarly Publishing (SSP), taking place May 28–30, 2025, at the Hilton Baltimore in Maryland. 

Impact Journals publishes scholarly journals in the biomedical sciences, with a focus on cancer and aging research.

Attendees are invited to stop by Booth #209 to meet members of the Oncotarget team and learn more about the journal’s latest initiatives. This year’s conference theme, Reimagining the Future of Scholarly Publishing at the Intersection of Value and Values,” highlights critical topics such as artificial intelligence, research ethics, and transparency in science—principles that closely align with Oncotarget's commitment to rigorous peer review and scientific integrity.

We look forward to connecting with SSP attendees to discuss Oncotarget’s mission, explore potential collaborations, and emphasize the role of open science in advancing cancer research and related fields.

___

About Oncotarget:

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: 

X
Facebook
YouTube
Instagram

LinkedIn

Pinterest

Spotify
, and available wherever you listen to podcasts

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact media@impactjournals.com.  



Copyright © 2025 Rapamycin Press LLC dba Impact Journals